NEW YORK (GenomeWeb News) – Natera and LifeLabs Medical Laboratory Services today announced a deal to distribute the Panorama non-invasive prenatal diagnostic test in Canada.

Natera's test was launched in March for the detection of trisomy 21, 18, and 13 and some sex chromosome abnormalities. Last month, detection of triploidy was added to the test.

Financial and other terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.